FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2741762034> ?p ?o ?g. }

• W2741762034 abstract "Poly (ADP-ribose) polymerases (PARP) are enzymes involved in DNA-damage repair. Inhibition of PARP is a promising strategy for targeting cancers with defective DNA-damage repair. Several PARP inhibitors are currently in trials in the adjuvant, neoadjuvant, and metastatic settings for the treatment of ovarian, BRCA-mutated breast, and other cancers. Glioma Stem Cells (GSCs) exhibit higher oxidative base damage, single-strand DNA breaks and genomic instability and is reliant on single-strand break repair/base excision repair to tolerate additional stress. PARP critical for maintaining genomic stability by regulating a variety of DNA damage repair mechanisms is constitutively activated in GSCs. In this study, we show that talazoparib – a unique PARP inhibitor exhibits a strong single agent activity to inhibit proliferation of GSCs in vitro and suppress tumor progression in GSCs xenografts. Talazoparib cytotoxic activity was through inhibiting PARylation and by trapping PARP-DNA complexes resulting in accumulation of DNA damage during replication and ultimately leading to apoptosis. More importantly, we found EFGR amplification, which occurs in about 45% of GBM as a biomarker of response to PARPi. Gene expression and RPPA data showed that GSCs with EGFR amplification were associated with increased ROS, basal expression of DNA repair proteins and more DNA damage following talazoparib treatment, which may partially explain the sensitivity of this group of GSCs to talazoparib. EGFR enzyme activity was important for PARPi sensitivity since kinase dead mutant of EGFR or EGFR knock down cell lines were resistant to PARPi as was also shown by decreased PARP/DNA complex formation. Talazoparib showed strong inhibition of tumor growth in subcutaneous glioma model and 20% increase in median survival in an intracranial model with a 10% blood brain penetration of talazoparib. These data provide mechanistic insights into the anti-cancer activity of PARP inhibitors with mechanistic rationale of PARP inhibition and potential EGFR amplification as biomarker in the development for precision cancer. Citation Format: Shaofang Wu, Feng Gao, Xiaolong Li, Jie Ding, Siyuan Zheng, Emmanuel Martinez-Ledesma, Ningping Feng, Erik Sulman, Roel Verhaak, John de Groot, Dimpy Koul, W.K.Alfred Yung. EGFR amplification-A candidate predictive biomarker of PARP inhibitor Talazoparib sensitivity in gliomas [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2017; 2017 Apr 1-5; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2017;77(13 Suppl):Abstract nr 1781. doi:10.1158/1538-7445.AM2017-1781" @default.
• W2741762034 created "2017-08-08" @default.
• W2741762034 creator A5003324293 @default.
• W2741762034 creator A5005930092 @default.
• W2741762034 creator A5025131780 @default.
• W2741762034 creator A5033263947 @default.
• W2741762034 creator A5035482209 @default.
• W2741762034 creator A5040971821 @default.
• W2741762034 creator A5054809773 @default.
• W2741762034 creator A5055183757 @default.
• W2741762034 creator A5071445059 @default.
• W2741762034 creator A5074242312 @default.
• W2741762034 creator A5074662422 @default.
• W2741762034 creator A5082826196 @default.
• W2741762034 date "2017-07-01" @default.
• W2741762034 modified "2023-09-25" @default.
• W2741762034 title "Abstract 1781: EGFR amplification-A candidate predictive biomarker of PARP inhibitor Talazoparib sensitivity in gliomas" @default.
• W2741762034 doi "https://doi.org/10.1158/1538-7445.am2017-1781" @default.
• W2741762034 hasPublicationYear "2017" @default.
• W2741762034 type Work @default.
• W2741762034 sameAs 2741762034 @default.
• W2741762034 citedByCount "0" @default.
• W2741762034 crossrefType "proceedings-article" @default.
• W2741762034 hasAuthorship W2741762034A5003324293 @default.
• W2741762034 hasAuthorship W2741762034A5005930092 @default.
• W2741762034 hasAuthorship W2741762034A5025131780 @default.
• W2741762034 hasAuthorship W2741762034A5033263947 @default.
• W2741762034 hasAuthorship W2741762034A5035482209 @default.
• W2741762034 hasAuthorship W2741762034A5040971821 @default.
• W2741762034 hasAuthorship W2741762034A5054809773 @default.
• W2741762034 hasAuthorship W2741762034A5055183757 @default.
• W2741762034 hasAuthorship W2741762034A5071445059 @default.
• W2741762034 hasAuthorship W2741762034A5074242312 @default.
• W2741762034 hasAuthorship W2741762034A5074662422 @default.
• W2741762034 hasAuthorship W2741762034A5082826196 @default.
• W2741762034 hasConcept C134935766 @default.
• W2741762034 hasConcept C143425029 @default.
• W2741762034 hasConcept C153911025 @default.
• W2741762034 hasConcept C178169997 @default.
• W2741762034 hasConcept C182979987 @default.
• W2741762034 hasConcept C185592680 @default.
• W2741762034 hasConcept C187206112 @default.
• W2741762034 hasConcept C2779138821 @default.
• W2741762034 hasConcept C502942594 @default.
• W2741762034 hasConcept C54355233 @default.
• W2741762034 hasConcept C552990157 @default.
• W2741762034 hasConcept C82381507 @default.
• W2741762034 hasConcept C86803240 @default.
• W2741762034 hasConceptScore W2741762034C134935766 @default.
• W2741762034 hasConceptScore W2741762034C143425029 @default.
• W2741762034 hasConceptScore W2741762034C153911025 @default.
• W2741762034 hasConceptScore W2741762034C178169997 @default.
• W2741762034 hasConceptScore W2741762034C182979987 @default.
• W2741762034 hasConceptScore W2741762034C185592680 @default.
• W2741762034 hasConceptScore W2741762034C187206112 @default.
• W2741762034 hasConceptScore W2741762034C2779138821 @default.
• W2741762034 hasConceptScore W2741762034C502942594 @default.
• W2741762034 hasConceptScore W2741762034C54355233 @default.
• W2741762034 hasConceptScore W2741762034C552990157 @default.
• W2741762034 hasConceptScore W2741762034C82381507 @default.
• W2741762034 hasConceptScore W2741762034C86803240 @default.
• W2741762034 hasLocation W27417620341 @default.
• W2741762034 hasOpenAccess W2741762034 @default.
• W2741762034 hasPrimaryLocation W27417620341 @default.
• W2741762034 hasRelatedWork W2058694977 @default.
• W2741762034 hasRelatedWork W2083138349 @default.
• W2741762034 hasRelatedWork W2104573784 @default.
• W2741762034 hasRelatedWork W2186124233 @default.
• W2741762034 hasRelatedWork W2336997490 @default.
• W2741762034 hasRelatedWork W2481569934 @default.
• W2741762034 hasRelatedWork W2549651109 @default.
• W2741762034 hasRelatedWork W2562402105 @default.
• W2741762034 hasRelatedWork W2565528596 @default.
• W2741762034 hasRelatedWork W2604403187 @default.
• W2741762034 hasRelatedWork W2612722949 @default.
• W2741762034 hasRelatedWork W2740388256 @default.
• W2741762034 hasRelatedWork W2755843571 @default.
• W2741762034 hasRelatedWork W2885646768 @default.
• W2741762034 hasRelatedWork W2929293804 @default.
• W2741762034 hasRelatedWork W2981086035 @default.
• W2741762034 hasRelatedWork W3044867089 @default.
• W2741762034 hasRelatedWork W3049541627 @default.
• W2741762034 hasRelatedWork W3083494100 @default.
• W2741762034 hasRelatedWork W3125213762 @default.
• W2741762034 isParatext "false" @default.
• W2741762034 isRetracted "false" @default.
• W2741762034 magId "2741762034" @default.
• W2741762034 workType "article" @default.